bioanalytical laboratory Archives - AIT BioscienceAIT Bioscience


Tag Archives for bioanalytical laboratory

Scientific Expertise & High Performance = Winning Combination for Sponsors

If you’ve been involved in outsourcing projects to bioanalytical CROs for any length of time, you’ve probably sorted the CROs you work with into two groups: the ones who are really good at cranking through samples as long as you can provide them a robust method, and the ones who can solve the complex problems … read the full article » »

Categories: News, Quality Assurance and Electronic Laboratory Notebooks, Uncategorized

Other Tags: , ,

Comments Off on Scientific Expertise & High Performance = Winning Combination for Sponsors


AIT Bioscience Welcomes New Chief Scientific Officer

AIT Bioscience, LLC has named Shelby R. Anderson, Ph.D., as Chief Scientific Officer (CSO). Anderson replaces Ronald E. Shoup, Ph.D. in this role. Shoup served as the company’s scientific founder and has held executive leadership roles since September 2008, most recently as CSO since 2013. Shoup has been responsible for motivating the AIT Bioscience team … read the full article » »

Categories: News

Other Tags: , ,

Comments Off on AIT Bioscience Welcomes New Chief Scientific Officer


Bioanalytical Considerations for your Dermal Pharmaceutical Programs

Bioanalytical Considerations for your Dermal Pharmaceutical Programs Does your drug require sustained release or suffer from first pass metabolism losses?   Have you considered transdermal delivery via cream gel or patch?   How does bioanalysis differ for oral or dermal delivery?   The dermis is the largest organ of the human body and provides a … read the full article » »

Categories: LC-MS/MS Methods, Screening Assay, Special Topics

Other Tags: , , , ,

Comments Off on Bioanalytical Considerations for your Dermal Pharmaceutical Programs


Involved in Ocular Therapeutics? Thoughts on a successful PK program

As our population ages there comes an increased demand for therapies to treat age related ocular diseases such as Age-related Macular Degeneration (AMD), glaucoma, diabetic retinopathy and dry-eye.  In fact, the global market for ocular drugs is expected to reach $21.6 billion by 2018 according to a Transparency Market Research article.   Successful bioanalysis in … read the full article » »

Categories: Special Topics

Other Tags: , , , ,

Comments Off on Involved in Ocular Therapeutics? Thoughts on a successful PK program